Noumed Life Sciences Invests in GEA MODUL™ Q Tablet Press Technology

2018-07-19
Noumed Life Sciences, an integrated generics pharmaceutical company that offers a wide range of services and a variety of products, has purchased three MODUL™ Q tablet presses from GEA, along with multiple Exchangeable Compression Module (ECM) turrets to maximize the equipment’s capability and efficiency.
To view the complete content, please log in.
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
 
 
Midez MBT